Vitro Diagnostics/DBA Vitro Biopharma: Vitro Biopharma Inc. July 31st 2021; 3rd Quarter ended Financial Results of Operations and Shareholder Letter.

GOLDEN, CO / ACCESSWIRE / October 10, 2021 / Vitro Biopharma, Inc. dba Vitro Biopharma, announced its 3rd quarter, ended July 31st 2021, financial results of operations.Vitro Biopharma recorded increased

Related Keywords

New York ,United States ,Kuala Lumpur ,Malaysia ,Australia ,Delaware ,California ,Antigua And Barbuda ,Canada ,New York Stock Exchange ,Denver ,Colorado ,Bahamas ,The ,Cayman Islands ,The Bahamas ,Antigua ,Fitore Infinivive ,Jack Zamora ,Nathan Haas ,Johnr Evans ,Caroline Mosessian ,Asia Pacific ,Tiana States ,Jim Musick ,Conville Brown ,Tanner Haas ,York Stock Exchange ,Vitro Biopharma Inc ,Cu Anschutz Medical Center ,Stem Cell Centers Of Excellence ,Partner Stem Cell Centre ,European Wellness Biomedical Group ,Fitore Inc ,Foundation For Orthopedics ,Exchange Commission ,Prodromos Stem Cell Institute ,Practice Technology Innovation Leadership ,Partners Stem Cell Centre ,Vitro Biopharma ,Allorx Stem Cells ,Allorx Stem Cell ,Long Covid ,Kidney Disease ,Multiple Sclerosis ,Traumatic Brain Injury ,Orphan Drug Designation ,Allorx Stem ,Pitt Hopkins Syndrome ,Medical Center ,Drug Designation ,Spectrum Disorder ,Quality Management System ,Device Standard ,Stem Cells ,Medical Pavilion ,Middle East Our ,Cabo San Lucas Mexico ,Fitore Nutrition ,Easy Sleep ,Cell Serum ,Clinical Trial ,Musculoskeletal Conditions ,Nassau Based Medical Pavilion ,Principal Investigator ,Stem Cell Centre ,Medical Director ,Prodromos Stem Cell Institute Medical Director ,Cabo Mexico ,Wellness Biomedical Group ,Intellectual Property ,Convertible Preferred Stock ,Convertible Preferred ,New York Mellon ,New York Stock ,Stem Cell Tools ,Stem Cell Centers ,Umbilical Cord Mesenchymal Stem Cells ,Grow Brand ,Invitro ,Iagnostics ,Iopharma ,July ,1st ,021 ,Quarter ,Nded ,Financial ,Results ,Operations ,Shareholder ,Setter ,